Sandoz is targeting growth opportunities in the respiratory complex generics space with the acquisition of UK-based drug delivery device firm Coalesce.
Sandoz has revealed its latest move to capture growth opportunities in respiratory and complex generics with the announcement that it has acquired UK-based drug delivery device development company Coalesce Product Development Limited.
While financial details of the transaction and specific product opportunities were not revealed by the Novartis subsidiary – which is...
Melinta Therapeutics has prevailed at the Federal Circuit in a patent dispute over its reformulated intravenous antibiotic Minocin, with the appeals court upholding both infringement and validity and leaving Nexus Pharmaceuticals barred from launching a generic until 2031.
Mounjaro, Eliquis, and Darzalex buck the Q1 trend to make gains
